| ORIGINAL ARTICLE |
|
| Year : 2017 | Volume
: 16
| Issue : 1 | Page : 62-68 |
|
|
Development and evaluation of nanosized aripiprazole-loaded bioflexy films using a biopolymer from Lagenaria siceraria for brain delivery through orosoft palatal mucosal platform
NV Satheesh Madhav PhD , Vishakha Jaiswal, Abhijeet Ojha
Drug Delivery Research Laboratory, Faculty of Pharmacy, DIT University, Dehradun, India
Correspondence Address:
N V Satheesh Madhav
Drug Delivery Research Laboratory, Faculty of Pharmacy, DIT University, Makkawala, P.O. Bhagwantpur, Dehradun 248009, Uttarakhand
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1687-4315.205832
|
|
|
Purpose
The National Institute of Mental Health estimated the global cost of mental illness to be $6T by 2030. The purpose of the study was to deliver aripiprazole for brain targeting by suitably designing a bioflexy film for the treatment of different brain disorders.
Materials and methods
Bioflexy films were prepared by solvent casting technique using aripiprazole as a model drug, different concentrations of isolated biopolymer from Lagenaria siceraria, and a standard polymer.
Results
All formulations of aripiprazole were flexible, smooth, and transparent in nature, with a weight range from 23.73 to 34.48 mg, pH range from 7.27 to 7.39, and folding endurance of 94–116 times. The content uniformity was in the range of 97.2–98.6.
Conclusion
In-vitro and in-vivo release shows FL2 as the best formulation. On the basis in-vitro and in-vivo drug release, FL2 was found to be best formulation showing mucoadhesivity (36 h), t50% of 2.5 h, t80% of 23.4 h, and having R2 value of 0.9923, best-fit model Higuchi matrix analyzed by BIT-SOFT 1.12. Moreover, it was observed that significant amount of drug reaches to the brain through soft palatal route through neural pathway.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
